文献速递其他结缔组织病

系统性硬化症胃肠道受累:饮食与微生物组的作用

Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome.
PubMed 文献 · Semin Arthritis Rheum · 2023-02-24

在66例成人系统性硬化症患者中,胃肠道症状总评分加重与物种多样性降低及微生物组成差异相关,致病共生菌属如克雷伯菌属和肠球菌属显著增多;低FODMAP饮食组与非低FODMAP饮食组在胃肠道症状严重程度及α、β多样性上无显著差异,非低FODMAP组肠球菌属丰度更高。

要点

  • 胃肠道症状总评分加重与物种多样性降低及微生物组成差异相关。
  • 胃肠道症状严重度增加的患者中克雷伯菌属和肠球菌属等致病共生菌属显著更丰富。
  • 低FODMAP组与非低FODMAP组胃肠道症状严重程度及α、β多样性无显著差异。

核心结论

  • 报告更严重胃肠道症状的系统性硬化症患者表现出胃肠道微生物失调,特征为物种多样性减少和微生物组成改变。
  • 低FODMAP饮食与胃肠道微生物组成显著改变或系统性硬化症胃肠道症状减轻无关;然而需要随机对照试验评估特定饮食对系统性硬化症胃肠道症状的影响。

研究设计与样本

  • 连续招募成人系统性硬化症患者提供粪便标本进行细菌16S rRNA基因测序。
  • 患者完成UCLA硬皮病临床试验联盟胃肠道量表(GIT 2.0)和饮食史问卷(DHQ)II,并被分类为坚持低或非低FODMAP饮食。
  • 共纳入66例系统性硬化症患者,多数为女性(n=56),平均病程9.6年;35名参与者完成了DHQ II。
  • 胃肠道微生物差异采用三种α多样性指标(物种丰富度、均匀度和系统发育多样性)以及β多样性(整体微生物组成)评估。
  • 进行差异丰度分析以识别与系统性硬化症胃肠道表型及低与非低FODMAP饮食相关的特定菌属。

主要发现

  • 胃肠道症状严重度增加(GIT 2.0总评分)与物种多样性降低及胃肠道微生物组成差异相关。
  • 致病共生菌属(如克雷伯菌属和肠球菌属)在胃肠道症状严重度增加的患者中显著更丰富。
  • 低FODMAP组(N=19)与非低FODMAP组(N=16)比较,胃肠道症状严重程度及α和β多样性无显著差异。
  • 与非低FODMAP组相比,非低FODMAP组致病共生菌肠球菌属丰度更高。

局限性

  • 需要随机对照试验评估特定饮食对系统性硬化症胃肠道症状的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alterations in gastrointestinal (GI) microbial composition have been reported in patients with systemic sclerosis (SSc). However, it is unclear to what degree these alterations and/or dietary changes contribute to the SSc-GI phenotype. OBJECTIVES: Our study aimed to 1) evaluate the relationship between GI microbial composition and SSc-GI symptoms, and 2) compare GI symptoms and GI microbial composition between SSc patients adhering to a low versus non-low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet. METHODS: Adult SSc patients were consecutively recruited to provide stool specimens for bacterial 16S rRNA gene sequencing. Patients completed the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (GIT 2.0) and the Diet History Questionnaire (DHQ) II and were classified as adhering to a low or non-low FODMAP diet. GI microbial differences were assessed using three metrics of alpha diversity (species richness, evenness, and phylogenetic diversity), as well as beta diversity (overall microbial composition). Differential abundance analysis was performed to identify specific genera associated with SSc-GI phenotype and low versus non-low FODMAP diet. RESULTS: Of the 66 total SSc patients included, the majority were women (n = 56) with a mean disease duration of 9.6 years. Thirty-five participants completed the DHQ II. Increased severity of GI symptoms (total GIT 2.0 score) was associated with decreased species diversity and differences in GI microbial composition. Specifically, pathobiont genera (e.g., Klebsiella and Enterococcus) were significantly more abundant in patients with increased GI symptom severity. When comparing low (N = 19) versus non-low (N = 16) FODMAP groups, there were no significant differences in GI symptom severity or in alpha and beta diversity. Compared with the low FODMAP group, the non-low FODMAP group had greater abundance of the pathobiont Enterococcus. CONCLUSION: SSc patients reporting more severe GI symptoms exhibited GI microbial dysbiosis characterized by less species diversity and alterations in microbial composition. A low FODMAP diet was not associated with significant alterations in GI microbial composition or reduced SSc-GI symptoms; however, randomized controlled trials are needed to evaluate the impact of specific diets on GI symptoms in SSc.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Nguyen AD, Andréasson K, McMahan ZH, et al. Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome. Semin Arthritis Rheum. 2023. PMID: 36870237. doi:10.1016/j.semarthrit.2023.152185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。